nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonazepam—NAT2—urine—nephrolithiasis	0.114	0.509	CbGeAlD
Clonazepam—Knee pain—Hydrochlorothiazide—nephrolithiasis	0.0854	0.141	CcSEcCtD
Clonazepam—Airway obstruction NOS—Hydrochlorothiazide—nephrolithiasis	0.0491	0.0811	CcSEcCtD
Clonazepam—Obstructive airways disorder—Hydrochlorothiazide—nephrolithiasis	0.0355	0.0587	CcSEcCtD
Clonazepam—NAT2—renal system—nephrolithiasis	0.0278	0.125	CbGeAlD
Clonazepam—ALB—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.0209	0.122	CbGpPWpGaD
Clonazepam—CYP2E1—urine—nephrolithiasis	0.0168	0.0751	CbGeAlD
Clonazepam—Joint swelling—Hydrochlorothiazide—nephrolithiasis	0.0164	0.0271	CcSEcCtD
Clonazepam—Sleep disturbance—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0238	CcSEcCtD
Clonazepam—CYP3A4—urine—nephrolithiasis	0.0135	0.0604	CbGeAlD
Clonazepam—Toothache—Hydrochlorothiazide—nephrolithiasis	0.0132	0.0219	CcSEcCtD
Clonazepam—NAT2—Phase II conjugation—SLC26A1—nephrolithiasis	0.0122	0.0707	CbGpPWpGaD
Clonazepam—Heartburn—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0193	CcSEcCtD
Clonazepam—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.0103	0.017	CcSEcCtD
Clonazepam—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00868	0.0144	CcSEcCtD
Clonazepam—Gout—Hydrochlorothiazide—nephrolithiasis	0.00863	0.0143	CcSEcCtD
Clonazepam—ALB—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.00835	0.0486	CbGpPWpGaD
Clonazepam—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0082	0.0136	CcSEcCtD
Clonazepam—TSPO—nephron tubule—nephrolithiasis	0.00781	0.035	CbGeAlD
Clonazepam—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00728	0.012	CcSEcCtD
Clonazepam—NAT2—Biological oxidations—SLC26A1—nephrolithiasis	0.00711	0.0414	CbGpPWpGaD
Clonazepam—TSPO—renal system—nephrolithiasis	0.0071	0.0318	CbGeAlD
Clonazepam—TSPO—kidney—nephrolithiasis	0.00686	0.0308	CbGeAlD
Clonazepam—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00675	0.0112	CcSEcCtD
Clonazepam—TSPO—cortex of kidney—nephrolithiasis	0.00668	0.0299	CbGeAlD
Clonazepam—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00666	0.011	CcSEcCtD
Clonazepam—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00663	0.011	CcSEcCtD
Clonazepam—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0063	0.0104	CcSEcCtD
Clonazepam—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00622	0.0103	CcSEcCtD
Clonazepam—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00617	0.0102	CcSEcCtD
Clonazepam—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00614	0.0102	CcSEcCtD
Clonazepam—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.0058	0.00959	CcSEcCtD
Clonazepam—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00575	0.00951	CcSEcCtD
Clonazepam—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00575	0.00951	CcSEcCtD
Clonazepam—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00564	0.00933	CcSEcCtD
Clonazepam—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00554	0.00916	CcSEcCtD
Clonazepam—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0055	0.00909	CcSEcCtD
Clonazepam—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.0054	0.00892	CcSEcCtD
Clonazepam—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00534	0.00883	CcSEcCtD
Clonazepam—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00528	0.00873	CcSEcCtD
Clonazepam—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00526	0.0087	CcSEcCtD
Clonazepam—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00517	0.00855	CcSEcCtD
Clonazepam—GABRB2—Ion channel transport—CLCN4—nephrolithiasis	0.00517	0.0301	CbGpPWpGaD
Clonazepam—GABRB2—Ion channel transport—CLCN5—nephrolithiasis	0.00517	0.0301	CbGpPWpGaD
Clonazepam—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00516	0.00852	CcSEcCtD
Clonazepam—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00505	0.00835	CcSEcCtD
Clonazepam—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00505	0.00835	CcSEcCtD
Clonazepam—GABRA3—Ion channel transport—CLCN5—nephrolithiasis	0.00493	0.0287	CbGpPWpGaD
Clonazepam—GABRA3—Ion channel transport—CLCN4—nephrolithiasis	0.00493	0.0287	CbGpPWpGaD
Clonazepam—GABRG2—Ion channel transport—CLCN5—nephrolithiasis	0.00473	0.0275	CbGpPWpGaD
Clonazepam—GABRG2—Ion channel transport—CLCN4—nephrolithiasis	0.00473	0.0275	CbGpPWpGaD
Clonazepam—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00473	0.00781	CcSEcCtD
Clonazepam—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.0047	0.00776	CcSEcCtD
Clonazepam—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00467	0.00772	CcSEcCtD
Clonazepam—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00465	0.00769	CcSEcCtD
Clonazepam—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.0046	0.0076	CcSEcCtD
Clonazepam—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00453	0.00749	CcSEcCtD
Clonazepam—CYP2E1—nephron tubule—nephrolithiasis	0.00451	0.0202	CbGeAlD
Clonazepam—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00442	0.0073	CcSEcCtD
Clonazepam—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00438	0.00724	CcSEcCtD
Clonazepam—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00425	0.00703	CcSEcCtD
Clonazepam—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00423	0.00699	CcSEcCtD
Clonazepam—GABRA1—Ion channel transport—CLCN5—nephrolithiasis	0.00413	0.024	CbGpPWpGaD
Clonazepam—GABRA1—Ion channel transport—CLCN4—nephrolithiasis	0.00413	0.024	CbGpPWpGaD
Clonazepam—CYP2E1—renal system—nephrolithiasis	0.0041	0.0184	CbGeAlD
Clonazepam—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00405	0.0067	CcSEcCtD
Clonazepam—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00402	0.00665	CcSEcCtD
Clonazepam—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00401	0.00664	CcSEcCtD
Clonazepam—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00398	0.00659	CcSEcCtD
Clonazepam—CYP2E1—kidney—nephrolithiasis	0.00396	0.0178	CbGeAlD
Clonazepam—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0039	0.00644	CcSEcCtD
Clonazepam—CYP2E1—cortex of kidney—nephrolithiasis	0.00386	0.0173	CbGeAlD
Clonazepam—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00375	0.00621	CcSEcCtD
Clonazepam—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00357	0.00591	CcSEcCtD
Clonazepam—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00347	0.00574	CcSEcCtD
Clonazepam—Tension—Hydrochlorothiazide—nephrolithiasis	0.00346	0.00571	CcSEcCtD
Clonazepam—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00342	0.00565	CcSEcCtD
Clonazepam—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00341	0.00563	CcSEcCtD
Clonazepam—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00339	0.0056	CcSEcCtD
Clonazepam—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00332	0.00549	CcSEcCtD
Clonazepam—CYP3A4—renal system—nephrolithiasis	0.0033	0.0148	CbGeAlD
Clonazepam—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00545	CcSEcCtD
Clonazepam—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00327	0.0054	CcSEcCtD
Clonazepam—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00325	0.00538	CcSEcCtD
Clonazepam—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00324	0.00535	CcSEcCtD
Clonazepam—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00322	0.00532	CcSEcCtD
Clonazepam—CYP3A4—kidney—nephrolithiasis	0.00319	0.0143	CbGeAlD
Clonazepam—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00318	0.00525	CcSEcCtD
Clonazepam—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00316	0.00523	CcSEcCtD
Clonazepam—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00315	0.00521	CcSEcCtD
Clonazepam—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00311	0.00514	CcSEcCtD
Clonazepam—Cough—Hydrochlorothiazide—nephrolithiasis	0.00307	0.00508	CcSEcCtD
Clonazepam—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.003	0.00496	CcSEcCtD
Clonazepam—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.003	0.00496	CcSEcCtD
Clonazepam—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.003	0.00496	CcSEcCtD
Clonazepam—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00299	0.00494	CcSEcCtD
Clonazepam—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00296	0.0049	CcSEcCtD
Clonazepam—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00293	0.00485	CcSEcCtD
Clonazepam—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.0029	0.00479	CcSEcCtD
Clonazepam—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00287	0.00475	CcSEcCtD
Clonazepam—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00287	0.00475	CcSEcCtD
Clonazepam—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00281	0.00465	CcSEcCtD
Clonazepam—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0028	0.00464	CcSEcCtD
Clonazepam—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00274	0.00453	CcSEcCtD
Clonazepam—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00269	0.00444	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00262	0.00433	CcSEcCtD
Clonazepam—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0026	0.0043	CcSEcCtD
Clonazepam—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00424	CcSEcCtD
Clonazepam—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00255	0.00422	CcSEcCtD
Clonazepam—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00253	0.00418	CcSEcCtD
Clonazepam—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0025	0.00413	CcSEcCtD
Clonazepam—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00248	0.0041	CcSEcCtD
Clonazepam—Pain—Hydrochlorothiazide—nephrolithiasis	0.00246	0.00406	CcSEcCtD
Clonazepam—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00246	0.00406	CcSEcCtD
Clonazepam—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00391	CcSEcCtD
Clonazepam—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00235	0.00388	CcSEcCtD
Clonazepam—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00228	0.00377	CcSEcCtD
Clonazepam—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00227	0.00376	CcSEcCtD
Clonazepam—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00227	0.00376	CcSEcCtD
Clonazepam—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00212	0.0035	CcSEcCtD
Clonazepam—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00206	0.00341	CcSEcCtD
Clonazepam—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00203	0.00336	CcSEcCtD
Clonazepam—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00197	0.00325	CcSEcCtD
Clonazepam—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.0019	0.00314	CcSEcCtD
Clonazepam—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00183	0.00302	CcSEcCtD
Clonazepam—Rash—Hydrochlorothiazide—nephrolithiasis	0.00181	0.003	CcSEcCtD
Clonazepam—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00181	0.00299	CcSEcCtD
Clonazepam—Headache—Hydrochlorothiazide—nephrolithiasis	0.0018	0.00298	CcSEcCtD
Clonazepam—GABRB2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0018	0.0105	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0018	0.0105	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00172	0.00998	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00172	0.00998	CbGpPWpGaD
Clonazepam—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00171	0.00282	CcSEcCtD
Clonazepam—GABRG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00165	0.00957	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00165	0.00957	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GRHPR—nephrolithiasis	0.0016	0.00933	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.0016	0.00933	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00153	0.0089	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—SLC26A1—nephrolithiasis	0.00151	0.00877	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00147	0.00853	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00147	0.00853	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00147	0.00853	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00144	0.0084	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00144	0.00837	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00144	0.00837	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—AGXT—nephrolithiasis	0.00143	0.00832	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.0014	0.00814	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.0014	0.00814	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00134	0.0078	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00134	0.0078	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00132	0.00768	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00132	0.00768	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00128	0.00746	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—SLC26A1—nephrolithiasis	0.00122	0.00707	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—APRT—nephrolithiasis	0.00122	0.00707	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00117	0.00682	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00117	0.00682	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00111	0.00647	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00111	0.00647	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00106	0.00617	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00106	0.00617	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00103	0.00601	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00103	0.00601	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00102	0.00591	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00102	0.00591	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.001	0.00582	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.001	0.00582	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000986	0.00573	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000986	0.00573	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000945	0.0055	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000945	0.0055	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.000945	0.0055	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000931	0.00541	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000931	0.00541	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000921	0.00536	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000921	0.00536	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000889	0.00517	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000889	0.00517	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000879	0.00511	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000879	0.00511	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—AQP1—nephrolithiasis	0.000866	0.00504	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000842	0.0049	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000842	0.0049	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000829	0.00483	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000826	0.00481	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000826	0.00481	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000823	0.00479	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000823	0.00479	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CHRM3—nephrolithiasis	0.000783	0.00456	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000736	0.00428	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000736	0.00428	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000736	0.00428	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000734	0.00427	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000702	0.00409	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000699	0.00407	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000673	0.00392	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000671	0.0039	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000671	0.0039	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000589	0.00342	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000509	0.00296	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000509	0.00296	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—DGKH—nephrolithiasis	0.000487	0.00283	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—SLC7A9—nephrolithiasis	0.000487	0.00283	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000473	0.00275	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000473	0.00275	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000422	0.00245	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000422	0.00245	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GRHPR—nephrolithiasis	0.00034	0.00198	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000337	0.00196	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—AGXT—nephrolithiasis	0.000303	0.00176	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GRHPR—nephrolithiasis	0.000292	0.0017	CbGpPWpGaD
Clonazepam—ALB—Metabolism—AGXT—nephrolithiasis	0.000261	0.00152	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—APRT—nephrolithiasis	0.000258	0.0015	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—SLC26A1—nephrolithiasis	0.000258	0.0015	CbGpPWpGaD
Clonazepam—ALB—Metabolism—SLC26A1—nephrolithiasis	0.000221	0.00129	CbGpPWpGaD
Clonazepam—ALB—Metabolism—APRT—nephrolithiasis	0.000221	0.00129	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—AQP1—nephrolithiasis	0.000184	0.00107	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CHRM3—nephrolithiasis	0.000166	0.000966	CbGpPWpGaD
Clonazepam—ALB—Metabolism—AQP1—nephrolithiasis	0.000158	0.000918	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000158	0.000918	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CHRM3—nephrolithiasis	0.000143	0.00083	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000141	0.000818	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.00012	0.000696	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—APRT—nephrolithiasis	0.00012	0.000696	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—AQP1—nephrolithiasis	8.52e-05	0.000496	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CHRM3—nephrolithiasis	7.71e-05	0.000448	CbGpPWpGaD
